Summit Asset Management, LLC Bristol Myers Squibb CO Transaction History

Summit Asset Management, LLC

$841 Million
Q1 2024

A detailed history of Summit Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Summit Asset Management, LLC holds 7,943 shares of BMY stock, worth $315,019. This represents 0.05% of its overall portfolio holdings.

Number of Shares

7,943

Previous 8,498 6.53%

Holding current value

$315,019

Previous $436,000 1.38%

% of portfolio

0.05%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$47.98 - $54.4 $26,628 - $30,192	-555 Reduced 6.53%	7,943 $430,000
Q4 2023 Feb 06, 2024	BUY	$48.48 - $57.85 $29,087 - $34,710	600 Added 7.6%	8,498 $436,000
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $9,747 - $10,823	-153 Reduced 1.9%	7,898 $505,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $65 - $74	1 Added 0.01%	8,051 $558,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $68 - $81	1 Added 0.01%	8,050 $579,000

Q3 2022 Nov 07, 2022	BUY	$0.13 - $76.84 $9 - $5,839	76 Added 0.95%	8,049 $572,000
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $5,446 - $5,998	75 Added 0.95%	7,973 $614,000
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $49,184 - $58,976	800 Added 11.27%	7,898 $577,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $36,575 - $42,638	-682 Reduced 8.77%	7,098 $443,000
Q3 2021 Nov 08, 2021	SELL	$59.17 - $69.31 $32,247 - $37,773	-545 Reduced 6.55%	7,780 $460,000
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $9,905 - $10,787	-160 Reduced 1.89%	8,325 $556,000
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $4,747 - $5,339	-80 Reduced 0.93%	8,485 $536,000
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $48,790 - $55,288	845 Added 10.95%	8,565 $531,000
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $82,641 - $91,577	1,439 Added 22.91%	7,720 $465,000
Q2 2020 Aug 07, 2020	SELL	$54.82 - $64.09 $3,892 - $4,550	-71 Reduced 1.12%	6,281 $369,000
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $11,832 - $17,194	255 Added 4.18%	6,352 $354,000
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $14,724 - $16,282	-330 Reduced 5.13%	6,097 $276,000
Q1 2019 May 07, 2019	SELL	$45.12 - $53.8 $10,377 - $12,374	-230 Reduced 3.46%	6,427 $307,000
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $8,533 - $11,065	-175 Reduced 2.56%	6,657 $346,000
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $8,539 - $10,643	-169 Reduced 2.41%	6,832 $378,000
Q1 2018 May 07, 2018	SELL	$59.92 - $68.98 $4,434 - $5,104	-74 Reduced 1.05%	7,001 $443,000
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $8,031 - $8,756	-134 Reduced 1.86%	7,075 $434,000
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $398,153 - $459,501	7,209	7,209 $459,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Asset Management, LLC with notifications on news.

Account

Summit Asset Management, LLC Bristol Myers Squibb CO Transaction History